Back to search

Poland· PL-100410901

Oxybutyninum Aflofarm

A oxybutynin product containing oxybutynini hydrochloridum, registered in Poland by Aflofarm Farmacja Polska Sp. z o.o.. The same ATC class is registered in 18 of our 19 countries.

ATC G04BD04

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedOxybutyninum AflofarmATCG04BD04REGISTER NO.PL-100410901PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Oxybutynin is registered in 18 of 19 countries.

Countries holding a registration under ATC G04BD04 (oxybutynin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 10 of them publish a price we can compare per daily dose

Oxybutynin · ATC G04BD04

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of oxybutynin costs, country by country.

Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.17 in France to $2.99 in Switzerland — a ×18 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Oxybutynin · price per daily dose (15 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$2.99
  • IT Italy$0.59
  • US United States$0.20 (acquisition cost)
  • FR France$0.17
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Oxybutynini hydrochloridum
Manufacturer
Aflofarm Farmacja Polska Sp. z o.o.
Country
Poland (PL)
ATC code
G04BD04
ATC class
Oxybutynin
Defined daily dose
15 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

2 priced
  • gtin
    05909991427184
    30 szt.
    PLN 9.37
  • gtin
    05909991427191
    60 szt.
    PLN 17.65
  • gtin
    05909991427177

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

312 interactions on record for oxybutynin.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Oxybutynin · interactions on record

312 records

  • 3 severe
  • 103 moderate
  • 1 minor
  • 168 info

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • DicycloverineA03AA07moderate

37 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oxybutynin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oxybutynin products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Detrusan, Ditropan
  • Belgium · Oxybutynine Eg, Velariq
  • Bulgaria · Дриптан
  • Czechia · Tarraconiq, Uroxal
  • Germany · Dridase, Oxybutynin Aaa-Pharma
  • Denmark · Oxybutynin Macure, Oxybutynin Unimedic
  • Estonia · Driptane
  • Spain · Ditropan, Dresplan
  • Finland · Oxybutynin Macure, Oxybutynin Unimedic
  • France · Ditropan, Oxybutynine Accord
  • United Kingdom (Northern Ireland) · Ditropan, Oxybutynin Hydrochloride
  • Greece · Ditropan
  • Hungary · Ditropan, Uroxal
  • Ireland · Oxybutynin Hydrochloride Accord Healthcare Ireland, Oxybutynin Hydrochloride Syri Pharma
  • Iceland · Kentera
  • Italy · Ditropan, Ossibutinina Cloridrato Mylan Generics
  • Liechtenstein · Kentera
  • Lithuania · Driptane
  • Luxembourg · Oxybutynine Eg, Velariq
  • Latvia · Driptane
  • Netherlands · Dridase, Oxybutinin Hydrochloride Aurobindo
  • Norway · Kentera, Oxybutynin Macure
  • Portugal · Ditropan, Velariq
  • Romania · Driptane
  • Sweden · Ditropan, Oxybutynin Accord
  • Slovakia · Uroxal, Velariq

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ac1ee054-4667-4a39-892a-b1775d55d2d1
GET /v1/drugs/ac1ee054-4667-4a39-892a-b1775d55d2d1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "5 mg",
  "packaging": "05909991427177 ¦ Rp ¦ 135915\n10 tabl.\n05909991427184 ¦ Rp ¦ 135916\n30 tabl.\n05909991427191 ¦ Rp ¦ 135917\n60 tabl.",
  "substance": "Oxybutynini hydrochloridum 5 mg/ml",
  "common_name": "Oxybutynini hydrochloridum",
  "pl_product_id": "100410901",
  "pozwolenie_nr": "26181",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about oxybutynin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.